Redi Health Lands $14 Million Investment to Continue Improving Patient Health Outcomes by Connecting Pharma, Providers, and Patients in One Platform

Series B Funding Round Led by Blue Heron Capital, with Participation from North Coast Ventures, Refinery Ventures, Mutual Capital Partners, Rev1 Ventures, and M25 Redi Health today announced that it has closed $14 million in Series B funding. The funding round was led by Blue Heron Capital, with participation from North Coast Ventures and existing investors Refinery Ventures, Mutual Capital Partners, Rev1 Ventures, and M25. Redi Health will use the financing to foster innovation, develop and launch new products, expand its unique network, and accelerate overall growth. The funding underscores Redi Health’s success in reaching millions of patients across the country, solidifying its position as a leader in the digital health space. Luke Buchanan, Co-Founder and CEO at Redi Health stated, “We are at a pivotal moment in healthcare, where technology integration can significantly enhance patient care and outcomes. This new financing is a testament to the hard work of our team and the support of our investors. With Blue Heron Capital’s backing, we are poised to bring new products to market, expand our reach, and continue to innovate at the intersection of technology and healthcare. Our goal is to make comprehensive, patient-centered care accessible to millions more across the country.” Current Patient Support Programs (PSPs), which are typically provided by pharma to patients who are taking their complex, high-cost medications, have proven to make a signi...
Source: EMR and HIPAA - Category: Information Technology Authors: Tags: Health IT Company Healthcare IT Blue Heron Capital Gordon Crenshaw Health IT Funding Health IT Fundings Health IT Investment Jim Clair Luke Buchanan M25 Mutual Capital Partners North Coast Ventures Redi.Health Refinery Ventures Source Type: blogs